Intersect ENT

Employees:
300
Market Cap:
$671.34 million
Revenue:
$78.86 million
Net Income:
$-24.71 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Intersect ENT
Employees:
300
Market Cap:
$671.34 million
Revenue:
$78.86 million
Net Income:
$-24.71 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Mar 7, 7:10 PM

Heres the Manufacturing team behind PROPEL Contour, our newest steroid releasing implant. Important Safety info: bit.ly/2mqRnxZ

Mar 1, 4:11 PM

Meet PROPEL Contour, the newest member of the PROPEL family! Featuring an innovative hourglass design that conforms to the frontal (behind the forehead) or maxillary (behind the cheeks) sinus openings, PROPEL Contour focuses drug delivery and mechanical support where it is needed in order to optimize surgical outcomes. With this approval, Intersect ENTs PROPEL family of steroid releasing implants may be used in the treatment of patients undergoing ethmoid, frontal or maxillary surgeries, which represent the majority of procedures for the treatment of chronic sinusitis. Important Safety info: bit.ly/2mqRnxZ

Jan 13, 6:50 PM

We were pleased to be included in a Watermark panel on gender balance last night, along with fellow HR leaders from Ericsson, Genomic Health and the Center for Creative Leadership. We're proud to be included in the Watermark Index, a collaboration between Watermark and the University of California, Davis, which honors Bay Area companies that support the advancement of women and promote equal opportunity within their organizations. https://lnkd.in/gdMCxnQ

Jan 11, 0:26 AM

Intersect ENT president and CEO, Lisa Earnhardt, presented an overview of the companys business at the annual JP Morgan Healthcare Conference today. A webcast of the presentation will be available on the Investor Relations page of the our website: http://bit.ly/2ib0gOK.

2

Intersect ENT jobs